Myriad Genetics: Pamela Wong
Myriad Genetics has appointed Pamela Wong as its chief legal officer. Wong previously worked for Quest Diagnostics for 14 years, most recently as assistant general counsel. Prior to Quest, she worked for eight years at Baker-McKenzie, where she was an intellectual property partner, and at Pillsbury Winthrop Shaw Pittman. She holds a B.S. degree from the University of California, Berkeley, a Ph.D. from Florida State University, and a J.D. from the University of San Diego.
Becton Dickinson: Carrie Byington
Becton Dickinson has named infectious diseases specialist Carrie Byington to its board of directors. Byington is executive VP and head of University of California Health. Prior to UCH, Byington held leadership roles at the Texas A&M University System, including serving concurrently as dean of the college of medicine and senior vice president of health sciences for Texas A&M University and vice chancellor for health services for the Texas A&M 11-campus system. She also spent more than 20 years in teaching and leadership positions with the University of Utah.
Delfi Diagnostics: Tim McDaniel, Monique Cadle, Tobias Mann
Delfi Diagnostics has hired Tim McDaniel as VP of tech development, Monique Cadle as VP of people, and Tobias Mann as VP of software engineering.
Prior to joining Delfi, McDaniel was the senior VP of emerging opportunities at TGen, where he oversaw Ashion Analytics through its acquisition by Exact Sciences earlier this year. Prior to TGen, he led programs at Illumina to develop the company's core next-generation sequencing reagents and other consumables. Cadle joined Delfi earlier this year, bringing 15 years of experience in people operations and management consulting, as well as nonprofit management at companies and nonprofits including Grail, Deloitte, the US Agency for International Development, and 23andMe. Mann joined Delfi over the summer from Adaptive Biotechnologies, where he was the VP of software engineering. Prior to that, he held roles at Progenity and Illumina, developing next-generation sequencing products and applications.
For additional recent items on executive appointments and promotions in omics and molecular diagnostics, please see the People in the News page on our website.